These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 6752627

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [New antihypertensive agents].
    Hayduk K.
    Med Klin; 1979 Jul 27; 74(30):1107-15. PubMed ID: 39232
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
    Dupont AG, Vanderniepen P, Six RO.
    Bibl Cardiol; 1987 Jul 27; (42):161-7. PubMed ID: 3307757
    [No Abstract] [Full Text] [Related]

  • 27. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
    Schäfer N, Knaup G.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):249-52. PubMed ID: 6806612
    [No Abstract] [Full Text] [Related]

  • 28. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J, Jäger H.
    MMW Munch Med Wochenschr; 1980 Jan 25; 122(4):137-40. PubMed ID: 6767938
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 25; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 31. [The centrally acting antihypertensive drug guanfacine. Effect on lung function and circulatory parameters in hypertensive patients with bronchial asthma].
    Dorow P, Knaup G.
    ZFA (Stuttgart); 1983 Sep 30; 59(27):1520-4. PubMed ID: 6359750
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M, Weiss Y, Georges D.
    Arch Mal Coeur Vaiss; 1980 Oct 30; 73(10):1171-7. PubMed ID: 6778409
    [Abstract] [Full Text] [Related]

  • 35. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL, Ermolenko VM, Rozhdestvenskaia TM, Tatsievskiĭ VA, Panasiuk VV.
    Ter Arkh; 1984 Oct 30; 56(7):66-9. PubMed ID: 6385325
    [No Abstract] [Full Text] [Related]

  • 36. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
    Bune AJ, Chalmers JP, Graham JR, Howe PR, West MJ, Wing LM.
    Eur J Clin Pharmacol; 1981 Oct 30; 19(5):309-15. PubMed ID: 7016550
    [No Abstract] [Full Text] [Related]

  • 37. [Comparative study of the antihypertensive effect of guanfacine and guanethidine].
    Kállay K, Szám I, Káldi N.
    Orv Hetil; 1981 Jul 19; 122(29):1777-83. PubMed ID: 7027137
    [No Abstract] [Full Text] [Related]

  • 38. Experiences with guanfacine in a two-year follow-up study.
    Titscher G.
    Br J Clin Pharmacol; 1980 Jul 19; 10 Suppl 1(Suppl 1):83S-84S. PubMed ID: 6994785
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.